Last checked at 15 Dec 2020 22:00
UK TRADING UPDATE SUMMARY: Triple Point Social Ups Credit Facility
UK TRADING UPDATE SUMMARY: Triple Point Social Ups Credit Facility
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Oncimmune Share News (ONC)
ONC Share
Price
ONC Share
News
ONC Share
Chat
ONC Share
Trades2
ONC
Live RNS1
ONC Share
Charts
ONC Level 2
Console
ONC Live
Share Price
ONC Broker
Ratings
ONC Directors
Deals
ONC Financial
Diary
ONC
Fundamentals
ONC Short
Positions
ONC
Media
Oncimmune Information
Share Price Information for Oncimmune (ONC)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
24.50
Bid:
22.00
Ask:
25.00
Change:
0.00 (0.00%)
Spread:
3.00 (13.636%)
Open:
24.50
High:
0.00
Low:
0.00
Prev. Close:
24.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.14 Dec 2020 22:04
UK TRADING UPDATE SUMMARY: Novacyt Unveils New Test For Mink Covid
UK TRADING UPDATE SUMMARY: Novacyt Unveils New Test For Mink Covid
Read more14 Dec 2020 14:54
Oncimmune signs two NHS contracts, has NICE guidance published
(Sharecast News) - Oncimmune has signed a commercial contract to supply its 'EarlyCDT Lung' blood test to NHS Norfolk & Waveney Clinical Commissioning Group, it announced on Monday.
Read more16 Nov 2020 16:03
UK Shareholder Meetings Calendar - Next 7 Days
UK Shareholder Meetings Calendar - Next 7 Days
Read more11 Nov 2020 20:17
UK TRADING UPDATE SUMMARY: Mereo To Delist From AIM Amid Nasdaq Focus
UK TRADING UPDATE SUMMARY: Mereo To Delist From AIM Amid Nasdaq Focus
Read more11 Nov 2020 10:13
Oncimmune enters deal with Augmenta to profile plasma samples
(Sharecast News) - Immunodiagnostics group Oncimmune has signed a new master service agreement with Augmenta Bioworks, it announced on Wednesday, to profile patient plasma samples and characterise therapeutic candidates discovered through Augmenta's 'SingleCyte' and 'DeepGrid' discovery platforms.
Read more30 Oct 2020 14:53
IN BRIEF: Oncimmune Annual Loss Widens As Expenses Climb
IN BRIEF: Oncimmune Annual Loss Widens As Expenses Climb
Read more28 Oct 2020 17:43
UK TRADING UPDATE SUMMARY: Shoe Zone Ends Financial Year On Back Foot
UK TRADING UPDATE SUMMARY: Shoe Zone Ends Financial Year On Back Foot
Read more13 Oct 2020 17:59
IN BRIEF: Oncimmune In Covid Antibody Profiling Deal With Cedars-Sinai
IN BRIEF: Oncimmune In Covid Antibody Profiling Deal With Cedars-Sinai
Read more6 Oct 2020 19:28
UK TRADING UPDATE SUMMARY: Petra Strikes Deal With South African Union
UK TRADING UPDATE SUMMARY: Petra Strikes Deal With South African Union
Read more6 Oct 2020 13:54
Oncimmune granted funding for Covid-19 research collaboration
(Sharecast News) - Immunodiagnostics company Oncimmune Holdings announced the award of funding from UK Research and Innovation's (UKRI) 'Ideas to Address Covid-19' programme on Tuesday.
Read more23 Sep 2020 19:09
UK TRADING UPDATE SUMMARY: Joules In Lockdown Hit But Online Surges
UK TRADING UPDATE SUMMARY: Joules In Lockdown Hit But Online Surges
Read more23 Sep 2020 16:05
Oncimmune enters collaboration with Roche subsidiary
(Sharecast News) - Immunodiagnostics group Oncimmune Holdings has signed a collaboration with Roche subsidiary Genentech, it announced on Wednesday, to characterise the autoantibody profiles of patients in clinical trials for rheumatological diseases, including systemic lupus erythematosus (SLE).
Read more3 Sep 2020 20:34
IN BRIEF: Oncimmune Notes Publication Of Study Assessing EarlyCDT Lung
IN BRIEF: Oncimmune Notes Publication Of Study Assessing EarlyCDT Lung
Read more2 Sep 2020 16:06
IN BRIEF: Oncimmune Signs Autoantibody Profiling Programme Agreement
IN BRIEF: Oncimmune Signs Autoantibody Profiling Programme Agreement
Read more